Although exploratory in nature, this study raises the hypothesis that several metabolites, related to defective β-cell secretory function including adiponectin, glutamine, insulin secretory index HOMA-β%, pyruvate and gGT may contribute to improved GDM risk assessment in women with obesity. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.